Clinical Trials Browser

Phase 3 × Lung Neoplasms × icotinib × Clear all

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

Lung Neoplasms

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

Lung Neoplasms, Neoplasms